Literature DB >> 31811054

Clec10a regulates mite-induced dermatitis.

Kazumasa Kanemaru1,2, Emiko Noguchi3, Satoko Tahara-Hanaoka1,2,4, Seiya Mizuno5, Hiroaki Tateno4,6, Kaori Denda-Nagai7, Tatsuro Irimura7, Hiroshi Matsuda8, Fumihiro Sugiyama5, Satoru Takahashi5,9,10,11, Kazuko Shibuya1,2, Akira Shibuya12,2,4, Yasuhiro Fujisawa13, Yoshiyuki Nakamura13.   

Abstract

House dust mite (HDM) is a major allergen that causes allergic diseases such as atopic dermatitis. However, the regulatory mechanisms of HDM-induced immune responses are incompletely understood. NC/Nga mice are an inbred strain that is more susceptible to HDM and develops more severe dermatitis than other strains. Using whole-exome sequencing, we found that NC/Nga mice carry a stop-gain mutation in Clec10a, which encodes a C-type lectin receptor, Clec10a (MGL1/CD301a). The repair of this gene mutation using the CRISPR-Cas9 system ameliorated HDM-induced dermatitis, indicating that the Clec10a mutation is responsible for hypersensitivity to HDM in NC/Nga mice. Similarly, Clec10a -/- mice on the C57BL/6J background showed exacerbated HDM-induced dermatitis. Clec10a expressed on skin macrophages inhibits HDM-induced Toll-like receptor 4 (TLR4)-mediated inflammatory cytokine production through the inhibitory immunoreceptor tyrosine activating motif in its cytoplasmic portion. We identified asialoglycoprotein receptor 1 (Asgr1) as a functional homolog of mouse Clec10a in humans. Moreover, we found that a mucin-like molecule in HDM is a ligand for mouse Clec10a and human Asgr1. Skin application of the ligand ameliorated a TLR4 ligand-induced dermatitis in mice. Our findings suggest that Clec10a in mice and Asgr1 in humans play an important role in skin homeostasis against inflammation associated with HDM-induced dermatitis.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31811054     DOI: 10.1126/sciimmunol.aax6908

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  6 in total

1.  Evaluation of Glycan-Binding Specificity by Glycoconjugate Microarray with an Evanescent-Field Fluorescence Detection System.

Authors:  Lalhaba Oinam; Hiroaki Tateno
Journal:  Methods Mol Biol       Date:  2022

2.  Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo.

Authors:  Qing Wu; Xiumei Mo; Ying Lin; Junfeng Liu; Siqi Ye; Yu Zhang; Xingxing Fan; Dacan Chen; Fenggen Yan
Journal:  Ann Transl Med       Date:  2022-09

3.  A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma.

Authors:  Chuan Zhang; Dan Dang; Yuqian Wang; Xianling Cong
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

4.  Resolution of Eczema with Multivalent Peptides.

Authors:  Laura L Eggink; J Kenneth Hoober
Journal:  JID Innov       Date:  2022-07-07

Review 5.  ASGR1 and Its Enigmatic Relative, CLEC10A.

Authors:  J Kenneth Hoober
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

6.  The Immunological and Allergen Profiles of Patients with Atopic Dermatitis or Psoriasis.

Authors:  Magdalena Krupka-Olek; Andrzej Bożek; Aleksandra Kawczyk-Krupka
Journal:  Medicina (Kaunas)       Date:  2022-03-01       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.